These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4147 related articles for article (PubMed ID: 547726)

  • 1. Glucan induced inhibition of tumor growth and enhancement of survival in a variety of transplantable and spontaneous murine tumor models.
    Di Luzio NR; McNamee RB; Williams DL; Gilbert KM; Spanjers MA
    Adv Exp Med Biol; 1979; 121(A):269-90. PubMed ID: 547726
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucan:inhibition of tumor growth and enhancement of survival in four syngeneic murine tumor models.
    Di Luzio NR; McNamee R; Browder WI; Williams D
    Cancer Treat Rep; 1978 Nov; 62(11):1857-66. PubMed ID: 728903
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan.
    Di Luzio NR; Williams DL; McNamee RB; Edwards BF; Kitahama A
    Int J Cancer; 1979 Dec; 24(6):773-9. PubMed ID: 397198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Growth kinetics of transplantable mammary gland tumors in mice].
    Ostrovskaia LA; Vermel' EM
    Vopr Onkol; 1975; 21(10):77-88. PubMed ID: 1189355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of L-dopa, noradrenalin and adrenalin on P-388 mouse leukemia, B-16 mouse melanoma and E 0771 mammary carcinoma.
    Shohat B; Kott E; Bornstein B
    Experientia; 1975 Jan; 31(1):110-1. PubMed ID: 1112301
    [No Abstract]   [Full Text] [Related]  

  • 7. Tuftsin: an immunomodulating peptide hormone and its clinical potential as a natural biological response modifier.
    Nishioka K; Amoscato AA; Babcock GF; Banks RA; Phillips JH
    Cancer Invest; 1984; 2(1):39-49. PubMed ID: 6322938
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.
    Bissery MC; Guénard D; Guéritte-Voegelein F; Lavelle F
    Cancer Res; 1991 Sep; 51(18):4845-52. PubMed ID: 1680023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of murine leukemias by monoclonal antibody. I. Effect of passively administered antibody on growth of transplanted tumor cells.
    Kirch ME; Hammerling U
    J Immunol; 1981 Aug; 127(2):805-10. PubMed ID: 6788849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kinetics of the cell proliferation of murine mammary adenocarcinoma under the influence of methylcobalamine].
    Golenko OD; Arsenian FG; Miasishcheva NV; Sof'ina ZP
    Biull Eksp Biol Med; 1980 Feb; 89(2):185-7. PubMed ID: 7370419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyadenylic-polyuridylic acid, an adjunct to surgery in the treatment of spontaneous mammary tumors in C3H-He mice and transplantable melanoma in the hamster.
    Lacour F; Spira A; Lacour J; Prade M
    Cancer Res; 1972 Mar; 32(3):648-9. PubMed ID: 5061315
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
    Hong F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD
    Cancer Res; 2003 Dec; 63(24):9023-31. PubMed ID: 14695221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor immunity and the mechanism of polyinosinic-polycytidylic acid inhibition of tumor growth.
    Kreider JW; Benjamin SA
    J Natl Cancer Inst; 1972 Nov; 49(5):1303-10. PubMed ID: 4568087
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitory effect of polyinosinic:polycytidylic acid on the growth of transplantable mouse mammary carcinoma.
    Potmesil M; Goldfeder A
    Proc Soc Exp Biol Med; 1972 Apr; 139(4):1392-7. PubMed ID: 5023340
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucan induced modification of experimental Staphylococcus aureus infection in normal, leukemic and immunosuppressed mice.
    Williams DL; Di Luzio NR
    Adv Exp Med Biol; 1979; 121(A):291-306. PubMed ID: 547728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of amygdalin to arrest B16 melanoma and BW5147 AKR leukemia.
    Hill GJ; Shine TE; Hill HZ; Miller C
    Cancer Res; 1976 Jun; 36(6):2102-7. PubMed ID: 1268862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of growth of mouse mammary carcinoma by streptovaricin.
    Kramarsky B; Manthey WJ
    Proc Soc Exp Biol Med; 1974 Apr; 145(4):1434-9. PubMed ID: 4151254
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
    Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
    J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. II. In vitro cytotoxicity of lymphoid cells against normal and malignant syngeneic cells and against normal allogeneic cells.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):781-6. PubMed ID: 376706
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
    Fisher B; Gebhardt M
    Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 208.